|
|
||||||||
Original Research Communication |
-linolenic acid on circulating plasma lipids and fatty acid profiles in women1,2,3
1 From the Department of Human Biology and Nutritional Sciences, University of Guelph, Canada.
Background: Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and
-linolenic acid (GLA) have lipid-modifying and antiinflammatory properties. The effects of supplement mixtures of these fatty acids on plasma lipids and the fatty acid compositions of serum phospholipids have received little attention.
Objective: The objective was to determine the effects of different levels of GLA supplementation together with a constant intake of EPA plus DHA on the triacylglycerol-lowering effect of EPA plus DHA alone and on the fatty acid patterns (eicosanoid precursors) of serum phospholipids.
Design: Thirty-one women were assigned to 1 of 4 groups, equalized on the basis of their fasting triacylglycerol concentrations. They received supplements providing 4 g EPA+DHA (4:0, EPA+DHA:GLA; control group), 4 g EPA+DHA plus 1 g GLA (4:1), 2 g GLA (4:2), or 4 g GLA (4:4) daily for 28 d. Plasma lipids and fatty acids of serum phospholipids were measured on days 0 and 28.
Results: Plasma triacylglycerol concentrations were significantly lower on day 28 than on day 0 in the 4:0, 4:1, and 4:2 groups. LDL cholesterol decreased significantly (by 11.3%) in the 4:2 group. Dihomo-
-linolenic acid increased significantly in serum phospholipids only in the 4:2 and 4:4 groups; however, total n-3 fatty acids increased in all 4 groups.
Conclusions: A mixture of 4 g EPA+DHA and 2 g GLA favorably altered blood lipid and fatty acid profiles in healthy women. On the basis of calculated PROCAM values, the 4:2 group was estimated to have a 43% reduction in the 10-y risk of myocardial infarction.
Key Words: Eicosapentaenoic acid EPA n-3 fatty acids docosahexaenoic acid DHA arachidonic acid
-linolenic acid dihomo-
-linolenic acid triacylglycerols LDL cholesterol HDL cholesterol women
This article has been cited by other articles:
![]() |
K. Fekete, T. Marosvolgyi, V. Jakobik, and T. Decsi Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review Am. J. Clinical Nutrition, June 1, 2009; 89(6): 2070S - 2084S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajaram, E. H. Haddad, A. Mejia, and J. Sabate Walnuts and fatty fish influence different serum lipid fractions in normal to mildly hyperlipidemic individuals: a randomized controlled study Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1657S - 1663S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lindberg, I. Saltvedt, O. Sletvold, and K. S Bjerve Long-chain n-3 fatty acids and mortality in elderly patients Am. J. Clinical Nutrition, September 1, 2008; 88(3): 722 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rudkowska Functional foods for cardiovascular disease in women Menopause Int, June 1, 2008; 14(2): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jew, C. A. Vanstone, J.-M. Antoine, and P. J. H. Jones Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions J. Nutr., June 1, 2008; 138(6): 1228S - 1236S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids Nutr Clin Pract, August 1, 2006; 21(4): 323 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Arterburn, E. B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1467 - 1476S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A Castro, L. P Barroso, and P. Sinnecker Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach Am. J. Clinical Nutrition, July 1, 2005; 82(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Djousse, D. K. Arnett, J. J. Carr, J. H. Eckfeldt, P. N. Hopkins, M. A. Province, and R. C. Ellison Dietary Linolenic Acid Is Inversely Associated With Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study Circulation, June 7, 2005; 111(22): 2921 - 2926. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Djousse, D. K. Arnett, J. S. Pankow, P. N. Hopkins, M. A. Province, and R. C. Ellison Dietary Linolenic Acid Is Associated With a Lower Prevalence of Hypertension in the NHLBI Family Heart Study Hypertension, March 1, 2005; 45(3): 368 - 373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |